Eagle Pharmaceuticals amends rights agreement
- Investing.com
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Eagle Pharmaceuticals Inc (EGRX)
Eagle Pharmaceuticals Inc stock price live, this page displays OTC EGRX stock exchange data. View the EGRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Eagle Pharmaceuticals Inc real time stock price chart below.
What Is the Eagle Pharmaceuticals Inc Stock Price Today?
The Eagle Pharmaceuticals Inc stock price today is 3.000.
What Is the Stock Symbol for Eagle Pharmaceuticals Inc?
The stock ticker symbol for Eagle Pharmaceuticals Inc is EGRX.
Is EGRX the Same as $EGRX?
$EGRX is a common way to refer to the Eagle Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Eagle Pharmaceuticals Inc Trade On?
Eagle Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Eagle Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eagle Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Eagle Pharmaceuticals Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EGRX quote. (ISIN: US2697961082)
What Is the Eagle Pharmaceuticals Inc Stock Price Today?
The Eagle Pharmaceuticals Inc stock price today is 3.000.
What Is the Stock Symbol for Eagle Pharmaceuticals Inc?
The stock ticker symbol for Eagle Pharmaceuticals Inc is EGRX.
Is EGRX the Same as $EGRX?
$EGRX is a common way to refer to the Eagle Pharmaceuticals Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Eagle Pharmaceuticals Inc Trade On?
Eagle Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Eagle Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Eagle Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Eagle Pharmaceuticals Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the EGRX quote. (ISIN: US2697961082)
OTC Markets
Currency in USD
3.000
+0.105(+3.63%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.360
3.000
52 wk Range
0.003
6.370
EGRX Scorecard
Full Analysis
Significant return over the last week
EGRX is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.3603.000
52 wk Range
0.0036.370
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EGRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
- Eagle Pharmaceuticals to Delist from Nasdaq
- Investing.com
- Eagle Pharmaceuticals amends rights agreement
- Investing.com
- Eagle Pharmaceuticals to Delist from Nasdaq
- Investing.com
Eagle Pharmaceuticals Inc Company Profile
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Compare EGRX to Peers and Sector
Metrics to compare | EGRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEGRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −4.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price / Book | 0.0x | 2.7x | 2.6x | |
Price / LTM Sales | 0.0x | 8.9x | 3.0x | |
Upside (Analyst Target) | 0.0% | 174.0% | 49.2% | |
Fair Value Upside | Unlock | 7.1% | 7.4% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / 53.90M
People Also Watch
FAQ
What Is the Eagle Pharm (EGRX) Stock Price Today?
The Eagle Pharm stock price today is 3.00
What Stock Exchange Does Eagle Pharm Trade On?
Eagle Pharm is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Eagle Pharm?
The stock symbol for Eagle Pharm is "EGRX."
What Is the Eagle Pharm Market Cap?
As of today, Eagle Pharm market cap is 39.07M.
What Is Eagle Pharm's Earnings Per Share (TTM)?
The Eagle Pharm EPS (TTM) is 0.91.
When Is the Next Eagle Pharm Earnings Date?
Eagle Pharm will release its next earnings report on Aug 05, 2025.
From a Technical Analysis Perspective, Is EGRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Eagle Pharm Stock Split?
Eagle Pharm has split 0 times.
How Many Employees Does Eagle Pharm Have?
Eagle Pharm has 134 employees.
What is the current trading status of Eagle Pharm (EGRX)?
As of Jul 08, 2025, Eagle Pharm (EGRX) is trading at a price of 3.00, with a previous close of 3.00. The stock has fluctuated within a day range of 2.36 to 3.00, while its 52-week range spans from 0.00 to 6.37.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.